FDA.reportPublic FDA data

deutetrabenazine 9 MG Oral Tablet

RxCUI
1876922
RxNorm name
deutetrabenazine 9 MG Oral Tablet
Display name
deutetrabenazine 9 MG Oral Tablet
Full name
deutetrabenazine 9 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ea3c60a-45c7-44cc-afc2-d87fa53993c0deutetrabenazine 9 MG Oral Tablet [PSN] · deutetrabenazine 9 MG Oral Tablet [SCD]235These highlights do not include all the information needed to use AUSTEDO XR or AUSTEDO safely and effectively. See full prescribing information for AUSTEDO XR and AUSTEDO . AUSTEDO XR ® (deutetrabenazine) extended-release tablets, for oral use AUSTEDO ® (deutetrabenazine) tablets, for oral use Initial U.S. Approval: 201720250228